ETC
BIO icon

Exchange Traded Concepts’s Bio-Rad Laboratories Class A BIO Stock Holding History

Exchange Traded Concepts’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.2M Buy
72,116
+13,586
+23% +$3.85M 0.1% 196
2026
Q1 		$16.3M Buy
58,530
+28,938
+98% +$8.33M 0.12% 200
2025
Q4 		$8.97M Buy
29,592
+8,012
+37% +$2.5M 0.07% 283
2025
Q3 		$6.05M Buy
21,580
+7,648
+55% +$2.08M 0.05% 344
2025
Q2 		$3.36M Buy
13,932
+7,697
+123% +$1.82M 0.04% 395
2025
Q1 		$1.52M Buy
6,235
+3,973
+176% +$1.2M 0.03% 447
2024
Q4 		$743K Sell
2,262
-10
-0.4% -$3.39K 0.01% 703
2024
Q3 		$760K Sell
2,272
-884
-28% -$281K 0.02% 653
2024
Q2 		$862K Buy
3,156
+154
+5% +$44.8K 0.02% 485
2024
Q1 		$1.04M Buy
3,002
+355
+13% +$117K 0.03% 432
2023
Q4 		$855K Sell
2,647
-491
-16% -$154K 0.02% 437
2023
Q3 		$1.12M Sell
3,138
-708
-18% -$273K 0.03% 364
2023
Q2 		$1.46M Buy
3,846
+961
+33% +$391K 0.04% 321
2023
Q1 		$1.38M Sell
2,885
-911
-24% -$426K 0.04% 268
2022
Q4 		$1.6M Buy
3,796
+807
+27% +$326K 0.05% 221
2022
Q3 		$1.25M Buy
2,989
+188
+7% +$93.7K 0.04% 219
2022
Q2 		$1.39M Sell
2,801
-644
-19% -$335K 0.04% 227
2022
Q1 		$1.94M Buy
3,445
+46
+1% +$27.7K 0.04% 230
2021
Q4 		$2.57M Sell
3,399
-482
-12% -$361K 0.05% 220
2021
Q3 		$2.9M Sell
3,881
-1,733
-31% -$1.3M 0.07% 192
2021
Q2 		$3.62M Buy
5,614
+338
+6% +$206K 0.11% 136
2021
Q1 		$3.01M Buy
5,276
+1,701
+48% +$1.01M 0.11% 129
2020
Q4 		$2.08M Buy
3,575
+1,642
+85% +$935K 0.1% 139
2020
Q3 		$996K Buy
1,933
+578
+43% +$293K 0.06% 171
2020
Q2 		$612K Buy
1,355
+977
+258% +$431K 0.1% 168
2020
Q1 		$133K Buy
378
+150
+66% +$55.2K 0.07% 233
2019
Q4 		$84K Buy
+228
New +$80.4K 0.02% 223

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Exchange Traded Concepts's BIO Position: Q2 2026 in Review

Exchange Traded Concepts increased its Bio-Rad Laboratories Class A (BIO) stake by 23% in Q2 2026, buying an estimated $3.85M and bringing the position to 72,116 shares worth $21.2M. The position accounts for 0.1% of the portfolio, ranked #196.

Exchange Traded Concepts first reported a position in BIO in Q4 2019 and has held it in 27 quarters since. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Exchange Traded Concepts held 72,116 shares of Bio-Rad Laboratories Class A worth $21.2M as of Q2 2026.
  • Exchange Traded Concepts bought 13,586 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $3.85M.
  • Bio-Rad Laboratories Class A made up 0.1% of Exchange Traded Concepts's portfolio in Q2 2026, its #196 holding.
  • Exchange Traded Concepts first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and has held it in 27 quarters since.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.